Biological asset valuations are a necessity but can be volatile. However, since they use a conservative 20% discount rate in valuation, the valuation effectively allows for a 20%pa return on investment, which I am comfortable with. The question then becomes how much over the asset backing you are comfortable paying.
Biological asset valuations are a necessity but can be volatile....
Add ATP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.008(8.25%) |
Mkt cap ! $45.69M | |||
| Open | High | Low | Value | Volume |
| 9.6¢ | 11.0¢ | 9.6¢ | $127.8K | 1.254M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7423 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 74945 | 2 |
View Market Depth
| Last trade - 13.27pm 29/07/2024 (20 minute delay) ? |
| ATP (ASX) Chart |